Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-09-01

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA has approved a supplemental application for levothyroxine sodium from Amneal Pharmaceuticals NY LLC, updating labeling and related regulatory information fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)